A Perspective on the MARS2 Trial
Lim E, Opitz I, Woodard G, Bueno R, de Perrot M, Flores R, Gill R, Jablons D, Pass H. A Perspective on the MARS2 Trial. Journal Of Thoracic Oncology 2025, 20: 262-272. PMID: 39772349, DOI: 10.1016/j.jtho.2024.12.014.Peer-Reviewed Original ResearchConceptsPleural mesotheliomaPleurectomy decorticationTrial interpretationAssemble individualsAssociated with worse survivalPhase 3 randomized controlled trialsTime of randomizationTeam leadersResectable PMHistological subtypesPreoperative stagingWorse survivalSurgical mortalityConsensus guidelinesTeamAdverse eventsFacilitationChemotherapyPayer's willingnessSurgical communityTrialsSurgeryMesotheliomaQuality assuranceDecortication
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply